Explore more publications!

Symbotic Reports Fourth Quarter and Fiscal Year 2025 Results

WILMINGTON, Mass., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Symbotic Inc. (Nasdaq: SYM), a leader in A.I.-enabled robotics technology for the supply chain, announced financial results for its fourth fiscal quarter and fiscal year 2025, which ended on September 27, 2025. Symbotic reported revenue of $618 million, a net loss of $19 million and adjusted EBITDA1 of $49 million for the fourth quarter of fiscal year 2025.

In comparison, Symbotic posted revenue of $565 million, net income of $16 million and adjusted EBITDA1 of $42 million in the fourth quarter of fiscal year 2024.

Cash and cash equivalents increased by $467 million from the prior quarter, totaling $1,245 million at the end of the fourth quarter of fiscal year 2025.

For the full fiscal year 2025, Symbotic reported revenue of $2,247 million, reflecting 26% growth year-over-year, a net loss of $91 million, and adjusted EBITDA1 of $147 million.

“We delivered on our commitments to achieve strong top-line growth, a significant rise in operational systems, and strong margin expansion in fiscal year 2025 as we continue to enhance our value to customers,” said Rick Cohen, Symbotic Chairman and Chief Executive Officer. “We also added Medline, our first customer in the health care vertical, and enter fiscal year 2026 enthusiastic about our prospects to broaden opportunities with customers.”

“Revenue exceeded our expectations, and we delivered strong gross margin expansion and free cash flow in the fiscal fourth quarter of 2025,” said Izzy Martins, Symbotic Chief Financial Officer. “Looking ahead, the start of fiscal year 2026 is unfolding consistent with the expectations we outlined last quarter as our customers continue their transition to our next generation storage structure.”

OUTLOOK

For the first quarter of fiscal 2026, Symbotic expects revenue of $610 million to $630 million, and adjusted EBITDA2 of $49 million to $53 million.

WEBCAST INFORMATION

Symbotic will host a webcast today at 5:00 pm ET to discuss its fourth quarter and fiscal year 2025 results. The webcast link is: https://edge.media-server.com/mmc/go/Symbotic-Q4-2025.

________________________________
1 Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) is a non-GAAP financial measure as defined below under “Use of Non-GAAP Financial Information.” See the tables below for reconciliations to net income (loss), the most comparable GAAP measure.

2 Symbotic is not providing guidance for net income (loss), which is the most comparable GAAP financial measure to adjusted EBITDA, because information reconciling forward-looking adjusted EBITDA to net income (loss) is unavailable to it without unreasonable effort. Symbotic is not able to provide reconciliations of adjusted EBITDA to GAAP financial measures because certain items required for such reconciliations are outside of Symbotic’s control and/or cannot be reasonably predicted, such as the provision for stock-based compensation.


ABOUT SYMBOTIC

Symbotic is an automation technology leader reimagining the supply chain with its end-to-end, A.I.-powered robotic and software platform. Symbotic reinvents the warehouse as a strategic asset for the world’s largest retail, wholesale, and food & beverage companies. Applying next-generation technology, high-density storage and machine learning to solve today's complex distribution challenges, Symbotic enables companies to move goods with unmatched speed, agility, accuracy and efficiency. As the backbone of commerce, Symbotic transforms the flow of goods and the economics of the supply chain for its customers. For more information, visit www.symbotic.com.

USE OF NON-GAAP FINANCIAL INFORMATION

Symbotic reports its financial results in accordance with Generally Accepted Accounting Principles in the United States (“U.S. GAAP”). This press release contains financial measures that are not recognized under U.S. GAAP (“non-GAAP financial measures”), including adjusted EBITDA, adjusted gross profit, adjusted gross profit margin, adjusted research and development expenses, adjusted selling, general, and administrative expenses, and free cash flow. These non-GAAP financial measures have limitations as an analytical tool as they do not have a standardized meaning prescribed by U.S. GAAP. The non-GAAP financial measures Symbotic uses may not be the same non-GAAP financial measures, and may not be calculated in the same manner, as that of other companies and, therefore, are unlikely to be comparable to similar measures presented by other companies. Rather, these non-GAAP financial measures are provided as a supplement to corresponding U.S. GAAP measures to provide additional information regarding the results of operations from management’s perspective. Accordingly, non-GAAP financial measures should not be considered a substitute for, in isolation from, or superior to, the financial information prepared and presented in accordance with U.S. GAAP. All non-GAAP financial measures presented in this press release are reconciled to their closest reported U.S. GAAP financial measures. Symbotic recommends that investors review the reconciliation of these non-GAAP financial measures to the most directly comparable GAAP financial measures provided in the financial statement tables included below in this press release, and not rely on any single financial measure to evaluate its business.

Symbotic defines adjusted EBITDA, a non-GAAP financial measure, as GAAP net income (loss) excluding the following items: interest income; income taxes; depreciation and amortization of tangible and intangible assets; stock-based compensation; business combination transaction expenses; equity method investment; internal control remediation; business transformation costs; fair value adjustments on strategic investments; restructuring charges; joint venture formation fees; equity financing transaction costs; and other infrequent items that may arise from time to time. Symbotic defines adjusted gross profit, a non-GAAP financial measure, as GAAP gross profit excluding the following items: depreciation, stock-based compensation, and restructuring charges. Symbotic defines adjusted gross profit margin, a non-GAAP financial measure, as adjusted gross profit divided by total revenue. Symbotic defines adjusted research and development expenses, a non-GAAP financial measure, as GAAP research and development expenses excluding the following items: depreciation and amortization of tangible and intangible assets and stock-based compensation. Symbotic defines adjusted selling, general, and administrative expenses, a non-GAAP financial measure, as GAAP selling, general, and administrative expenses excluding the following items: depreciation and amortization of tangible and intangible assets; stock-based compensation; business combination transaction expenses; internal control remediation; business transformation costs; joint venture formation fees; equity financing transaction costs; and other infrequent items that may arise from time to time. Symbotic defines free cash flow, a non-GAAP financial measure, as net cash provided by or used in operating activities less purchases of property and equipment and capitalization of internal use software development costs. In addition to Symbotic’s financial results determined in accordance with U.S. GAAP, Symbotic believes that adjusted EBITDA, adjusted gross profit, adjusted gross profit margin, adjusted research and development expenses, adjusted selling, general, and administrative expenses, and free cash flow non-GAAP financial measures, are useful in evaluating the performance of Symbotic’s business because they highlight trends in its core business.

FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 including, but not limited to, Symbotic’s expectations or predictions of future financial or business performance or conditions. Forward-looking statements are inherently subject to risks, uncertainties and assumptions. Generally, statements that are not historical facts, including statements concerning our possible or assumed future actions, business strategies, events, backlog or results of operations, are forward-looking statements. These statements may be preceded by, followed by or include the words “believes,” “estimates,” “expects,” “projects,” “forecasts,” “may,” “will,” “should,” “seeks,” “plans,” “scheduled,” “anticipates” or “intends” or similar expressions.

Forward-looking statements include, but are not limited to, statements about the ability of or expectations regarding, Symbotic to:

  • meet the technical requirements of existing or future supply agreements with its customers, including with respect to existing backlog;
  • expand its target customer base and maintain its existing customer base;
  • realize the benefits expected from our GreenBox Systems LLC (“GreenBox”) joint venture, the commercial agreement with GreenBox, the commercial agreement with Nueva Wal Mart de México, S. de R.L. de C.V and the acquisition of the Advanced Systems and Robotics business from Walmart;
  • realize its outlook, including its system gross margin;
  • anticipate industry trends;
  • maintain and enhance its system;
  • anticipate rapid technological changes;
  • execute its growth strategy;
  • develop, design and sell systems that are differentiated from those of competitors;
  • execute its research and development strategy;
  • acquire, maintain, protect and enforce intellectual property;
  • attract, train and retain effective officers, key employees or directors;
  • comply with laws and regulations applicable to its business;
  • stay abreast of modified or new laws and regulations applying to its business;
  • successfully defend litigation;
  • issue equity securities in connection with future transactions;
  • meet future liquidity requirements and, if applicable, comply with restrictive covenants related to long-term indebtedness;
  • timely and effectively remediate any material weaknesses in its internal control over financial reporting;
  • maintain the listing of the Symbotic common stock on Nasdaq; and
  • effectively respond to general economic and business conditions.


Forward-looking statements also include, but are not limited to, statements with respect to:

  • the future performance of Symbotic’s business and operations;
  • expectations regarding revenues, expenses, adjusted EBITDA and anticipated cash needs;
  • expectations regarding cash flow, liquidity and sources of funding;
  • the next generation storage structure;
  • expectations regarding capital expenditures;
  • the anticipated benefits of Symbotic’s leadership structure;
  • the effects of pending and future legislation, regulation and trade practices, including tariffs;
  • business disruption;
  • disruption to the business due to Symbotic’s dependency on Walmart;
  • increasing competition in the warehouse automation industry;
  • any delays in the design, production or launch of Symbotic’s systems and products;
  • the failure to meet customers’ requirements under existing or future contracts or customer’s expectations as to price or pricing structure;   
  • any defects in new products or enhancements to existing products;  
  • the fluctuation of operating results from period to period due to a number of factors, including the pace of customer adoption of Symbotic’s new products and services and any changes in its product mix that shift too far into lower gross margin products; and
  • any consequences associated with joint ventures and legislative and regulatory actions and reforms.

Such forward-looking statements involve risks and uncertainties that may cause actual events, results or performance to differ materially from those indicated by such statements. Certain of these risks are identified and discussed in Symbotic’s Annual Report on Form 10-K for the fiscal year ended September 27, 2025, filed with the U.S. Securities and Exchange Commission (the “SEC”) on November 24, 2025. These risk factors will be important to consider in determining future results and should be reviewed in their entirety. These forward-looking statements are expressed in good faith, and Symbotic believes there is a reasonable basis for them. However, there can be no assurance that the events, results or trends identified in these forward-looking statements will occur or be achieved. Forward-looking statements are provided for the purposes of assisting the reader in understanding our financial performance, financial position and cash flows as of and for periods ended on certain dates and to present information about management’s current expectations and plans relating to the future, and the reader is cautioned not to place undue reliance on these forward-looking statements because of their inherent uncertainty and to appreciate the limited purposes for which they are being used by management. While we believe that the assumptions and expectations reflected in the forward-looking statements are reasonable based on information currently available to management, there is no assurance that such assumptions and expectations will prove to have been correct. Forward-looking statements speak only as of the date they are made and are based on the beliefs, estimates, expectations and opinions of management on that date. Symbotic is not under any obligation, and expressly disclaims any obligation to update, alter or otherwise revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law. Readers should carefully review the statements set forth in the reports that Symbotic has filed or will file from time to time with the SEC.

In addition to factors previously disclosed in Symbotic’s Annual Report on Form 10-K for the fiscal year ended September 27, 2025 filed with the SEC on November 24, 2025 and those identified elsewhere in this press release, the following factors, among others, could cause actual results to differ materially from forward-looking statements or historical performance.

Any financial projections in this press release or discussed in the webcast are forward-looking statements that are based on assumptions that are inherently subject to significant uncertainties and contingencies, many of which are beyond Symbotic’s control. While all projections are necessarily speculative, Symbotic believes that the preparation of prospective financial information involves increasingly higher levels of uncertainty the further out the projection extends from the date of preparation. The assumptions and estimates underlying the projected results are inherently uncertain and are subject to a wide variety of significant business, economic and competitive risks and uncertainties that could cause actual results to differ materially from those contained in the projections. The inclusion of projections in this communication should not be regarded as an indication that Symbotic, or its representatives, considered or considers the projections to be a reliable prediction of future events.

Annualized, projected and estimated numbers are not forecasts and may not reflect actual results.

This communication is not intended to be all-inclusive or to contain all the information that a person may desire in considering an investment in Symbotic and is not intended to form the basis of an investment decision in Symbotic. The forward-looking statements contained in this press release and other reports we file with, or furnish to, the SEC and other regulatory agencies and made by our directors, officers, other employees and other persons authorized to speak on our behalf are expressly qualified in their entirety by these cautionary statements.

INVESTOR RELATIONS CONTACT

Charlie Anderson
Vice President, Investor Relations & Corporate Development
ir@symbotic.com 

MEDIA INQUIRIES

mediainquiry@symbotic.com 

 
 
Symbotic Inc. and Subsidiaries
Consolidated Statements of Operations

       
  Three Months Ended   Year Ended
 (in thousands, except share and per share information) September 27, 2025   June 28, 2025   September 28, 2024   September 27, 2025   September 28, 2024
Revenue:                  
Systems $         582,329     $         559,108     $         536,447     $         2,118,868     $         1,705,440  
Software maintenance and support           9,271               8,121               5,893               29,602               14,173  
Operation services           26,857               24,892               22,226               98,452               68,566  
Total revenue           618,457               592,121               564,566               2,246,922               1,788,179  
Cost of revenue:                  
Systems           456,157               457,911               442,009               1,710,446               1,466,841  
Software maintenance and support           2,827               1,756               2,748               8,562               8,949  
Operation services           32,352               24,832               23,392               105,304               66,723  
Total cost of revenue           491,336               484,499               468,149               1,824,312               1,542,513  
Gross profit           127,121               107,622               96,417               422,610               245,666  
Operating expenses:                  
Research and development expenses           58,732               52,147               40,130               216,013               173,457  
Selling, general, and administrative expenses           83,638               75,670               45,399               298,730               188,934  
Restructuring charges           6,513               16,361               —               22,873               —  
Total operating expenses           148,883               144,178               85,529               537,616               362,391  
Operating income (loss)           (21,762 )             (36,556 )             10,888               (115,006 )             (116,725 )
Other income, net           8,076               8,451               9,416               36,063               37,042  
Income (loss) before income tax           (13,686 )             (28,105 )             20,304               (78,943 )             (79,683 )
Income tax benefit (expense)           423               (44 )             (4,110 )             1,627               (4,212 )
Loss from equity method investment           (5,885 )             (3,776 )             (240 )             (13,716 )             (777 )
Net income (loss)           (19,148 )             (31,925 )             15,954               (91,032 )             (84,672 )
Net income (loss) attributable to noncontrolling interests           (15,526 )             (26,012 )             13,118               (74,095 )             (71,182 )
Net income (loss) attributable to common stockholders $         (3,622 )   $         (5,913 )   $         2,836     $         (16,937 )   $         (13,490 )
                   
Income (loss) per share of Class A Common Stock:                  
Basic and Diluted(1) $         (0.03 )   $         (0.05 )   $         0.03     $         (0.16 )   $         (0.14 )
Weighted-average shares of Class A Common Stock outstanding:                  
Basic           111,697,093               109,201,745               104,146,479               108,670,159               95,697,368  
Diluted (2)   n/a       n/a       108,646,977       n/a       n/a  
 
(1) For the periods presented, basic and diluted EPS were calculated as the same value and as such presented on the same line.
(2) Periods in which the Company was in a net loss position diluted weighted-average shares of Class A Common Stock outstanding is the same as basic and as such indicated with “n/a”.


 
Symbotic Inc. and Subsidiaries
Reconciliation of Non-GAAP Financial Measures

 
The following table reconciles GAAP net income (loss) to Adjusted EBITDA:
 
  Three Months Ended   Year Ended
(in thousands) September 27, 2025   June 28, 2025   September 28, 2024   September 27, 2025   September 28, 2024
Net income (loss) $         (19,148 )   $         (31,925 )   $         15,954     $         (91,032 )   $         (84,672 )
Interest income           (8,085 )             (8,373 )             (9,353 )             (31,456 )             (36,907 )
Income tax (benefit) expense           (423 )             44               4,110               (1,627 )             4,212  
Depreciation and amortization           8,648               12,940               5,780               39,617               20,845  
Stock-based compensation           53,852               50,279               26,100               180,834               120,608  
Business combination transaction expenses           40               422               324               7,562               324  
Joint venture formation fees           —               —               —               —               1,089  
Restructuring charges           6,103               16,361               (775 )             22,233               33,431  
Internal control remediation           1,360               1,795                   8,406               —  
Business transformation costs           1,210               75                   3,685               —  
Fair value adjustments on strategic investments           —               —                   (4,481 )             —  
Equity financing transaction costs           —               —               —               —               1,985  
Equity method investment           5,885               3,776               240               13,716               777  
Adjusted EBITDA $         49,442     $         45,394     $         42,380     $         147,457     $         61,692  


The following table reconciles GAAP gross profit to Adjusted gross profit:  
   
  Three Months Ended
  Year Ended
 
(in thousands) September 27, 2025
  June 28, 2025
  September 28, 2024
  September 27, 2025
  September 28, 2024
Gross profit $         127,121       $         107,622       $         96,417       $         422,610       $         245,666    
Depreciation           1,457                 3,538                 2,208                 10,414                 7,748    
Stock-based compensation           8,672                 16,034                 3,260                 39,678                 15,654    
Restructuring charges           (411 )               —                 (775 )               (642 )               33,431    
Adjusted gross profit $         136,839       $         127,194       $         101,110       $         472,060       $         302,499    
                                                 
Gross profit margin   20.6   %     18.2   %     17.1   %     18.8   %     13.7   %
Adjusted gross profit margin   22.1   %     21.5   %     17.9   %     21.0   %     16.9   %


The following table reconciles GAAP research and development expenses to Adjusted research and development expenses:
 
  Three Months Ended   Year Ended
(in thousands) September 27, 2025   June 28, 2025   September 28, 2024   September 27, 2025   September 28, 2024
Research and development expenses $         58,732     $         52,147     $         40,130     $         216,013     $         173,457  
Depreciation and amortization           (4,946 )             (7,133 )             (1,647 )             (19,990 )             (4,883 )
Stock-based compensation           (16,494 )             (12,860 )             (11,553 )             (57,213 )             (53,266 )
Adjusted research and development expenses $         37,292     $         32,154     $         26,930     $         138,810     $         115,308  


The following table reconciles GAAP selling, general, and administrative expenses to Adjusted selling, general, and administrative expenses:
 
  Three Months Ended   Year Ended
(in thousands) September 27, 2025   June 28, 2025   September 28, 2024   September 27, 2025   September 28, 2024
Selling, general, and administrative expenses $         83,638     $         75,670     $         45,399     $         298,730     $         188,934  
Depreciation and amortization           (2,245 )             (2,270 )             (1,926 )             (9,214 )             (8,220 )
Stock-based compensation           (28,686 )             (21,385 )             (11,286 )             (83,943 )             (51,686 )
Business combination transaction expenses           (40 )             (422 )             (324 )             (7,562 )             (324 )
Internal control remediation           (1,359 )             (1,795 )             —               (8,406 )             —  
Business transformation costs           (1,210 )             (75 )             —               (3,685 )             —  
Joint venture formation fees           —               —               —               —               (1,089 )
Equity financing transaction costs           —               —               —               —               (1,985 )
Adjusted selling, general, and administrative expenses $         50,098     $         49,723     $         31,863     $         185,920     $         125,630  


The following table reconciles GAAP net cash provided by (used in) operating activities to free cash flow:
 
  Three Months Ended   Year Ended
(in thousands) September 27, 2025   June 28, 2025   September 28, 2024   September 27, 2025   September 28, 2024
Net cash provided by (used in) operating activities $         530,680     $         (138,343 )   $         (99,383 )   $         866,939     $         (58,077 )
Purchases of property and equipment and capitalization of internal use software development costs           (36,246 )             (14,867 )             (21,367 )             (79,030 )             (44,374 )
Free cash flow $         494,434     $         (153,210 )   $         (120,750 )   $         787,909     $         (102,451 )


 
Symbotic Inc. and Subsidiaries
Supplemental Common Share Information

 
Total Common Shares issued and outstanding:
 
  September 27, 2025
  September 28, 2024
Class A Common Shares issued and outstanding         112,635,932             104,689,377  
Class V-1 Common Shares issued and outstanding         74,693,311             76,965,386  
Class V-3 Common Shares issued and outstanding         403,559,196             404,309,196  
          590,888,439             585,963,959  


 
Symbotic Inc. and Subsidiaries
Consolidated Balance Sheets

 
(in thousands, except share data) September 27, 2025   September 28, 2024
ASSETS
Current assets:      
Cash and cash equivalents $         1,244,993     $         727,310  
Accounts receivable           186,705               201,548  
Unbilled accounts receivable           181,658               218,233  
Inventories           164,390               106,136  
Deferred expenses           20,532               1,058  
Prepaid expenses and other current assets           92,050               101,252  
Total current assets           1,890,328               1,355,537  
Property and equipment, net           117,649               97,109  
Intangible assets, net           79,149               3,664  
Goodwill           59,871               —  
Equity method investment           123,034               81,289  
Other assets           131,166               40,953  
Total assets $         2,401,197     $         1,578,552  
LIABILITIES AND EQUITY
Current liabilities:      
Accounts payable $         286,669     $         175,188  
Accrued expenses and other current liabilities           200,442               165,644  
Deferred revenue           1,242,312               676,314  
Total current liabilities           1,729,423               1,017,146  
Deferred revenue           124,932               129,233  
Other liabilities           63,629               42,043  
Total liabilities           1,917,984               1,188,422  
Commitments and contingencies           —               —  
Equity:      
Class A Common Stock, 3,000,000,000 shares authorized, 112,635,932 and 104,689,377 shares issued and outstanding at September 27, 2025 and September 28, 2024, respectively           13               13  
Class V-1 Common Stock, 1,000,000,000 shares authorized, 74,693,311 and 76,965,386 shares issued and outstanding at September 27, 2025 and September 28, 2024, respectively           7               7  
Class V-3 Common Stock, 450,000,000 shares authorized, 403,559,196 and 404,309,196 shares issued and outstanding at September 27, 2025 and September 28, 2024, respectively           40               40  
Additional paid-in capital           1,564,815               1,523,692  
Accumulated deficit           (1,340,862 )             (1,323,925 )
Accumulated other comprehensive loss           (2,695 )             (2,594 )
Total stockholders' equity           221,318               197,233  
Noncontrolling interest           261,895               192,897  
Total equity           483,213               390,130  
Total liabilities and equity $         2,401,197     $         1,578,552  


 
Symbotic Inc. and Subsidiaries
Consolidated Statements of Cash Flows

 
  Three Months Ended   Year Ended
(in thousands) September 27, 2025   June 28, 2025   September 28, 2024   September 27, 2025   September 28, 2024
Cash flows from operating activities:                  
Net income (loss) $         (19,148 )   $         (31,925 )   $         15,954     $         (91,032 )   $         (84,672 )
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:                  
Depreciation and amortization           8,650               12,941               5,781               39,604               20,847  
Amortization of leases           1,353               1,261               651               4,525               2,633  
Restructuring of leases           3,469               —               —               3,469               —  
Loss from equity method investment           5,885               3,776               240               13,716               777  
Foreign currency (gains) losses, net           40               (61 )             —               (33 )             (8 )
Loss on disposal of assets           63               —               337               264               337  
Gain on investments           —               —               —               —               (10,084 )
Provision for excess and obsolete inventory           2,247               3,921               (775 )             7,148               33,330  
Deferred taxes, net           (4,205 )             —               3,917               (4,205 )             3,917  
Stock-based compensation           64,368               49,440               25,350               183,936               112,208  
Gain from strategic investment fair value adjustment           —               —               —               (4,481 )             —  
Changes in operating assets and liabilities:                  
Accounts receivable           (50,495 )             1,389               (101,010 )             15,075               (132,305 )
Inventories           (28,690 )             3,470               30,202               (58,876 )             103  
Prepaid expenses and other current assets           7,685               (37,107 )             (114,889 )             70,386               (112,050 )
Deferred expenses           (1,589 )             27,503               5,690               21,993               (4,936 )
Other assets           25,624               (9,449 )             (4,088 )             8,696               (9,040 )
Accounts payable           56,360               (4,407 )             47,399               96,904               65,270  
Accrued expenses and other current liabilities           17,969               12,532               (10,126 )             10,356               38,467  
Deferred revenue           489,118               (171,331 )             6,309               606,406               18,318  
Acquisition-related consideration paid to customer           (45,000 )             —               —               (45,000 )             —  
Other liabilities           (3,024 )             (296 )             (10,325 )             (11,912 )             (1,189 )
Net cash provided by (used in) operating activities           530,680               (138,343 )             (99,383 )             866,939               (58,077 )
Cash flows from investing activities:                  
Purchases of property and equipment and capitalization of software development costs           (36,246 )             (14,867 )             (21,367 )             (79,030 )             (44,374 )
Proceeds from maturities of marketable securities           —               —               —               —               340,000  
Purchases of marketable securities           —               —               —               —               (48,660 )
Acquisitions of strategic investments           (87,656 )             (24,233 )             (23,996 )             (129,881 )             (90,485 )
Cash paid for business acquisitions           58,169               —               —               (141,831 )             —  
Net cash provided by (used in) investing activities           (65,733 )             (39,100 )             (45,363 )             (350,742 )             156,481  
Cash flows from financing activities:                  
Payment for taxes related to net share settlement of stock-based compensation awards           —               —               —               (3,012 )             (3,181 )
Net proceeds from issuance of common stock under employee stock purchase plan           1,622               —               2,308               4,855               5,743  
Proceeds from issuance of Class A Common Stock           —               —               —               —               257,985  
Distributions to or on behalf of Symbotic Holdings LLC partners           —               57               (561 )             (1,175 )             (48,215 )
Proceeds from exercise of warrants           —               —               —               —               158,704  
Net cash provided by financing activities           1,622               57               1,747               668               371,036  
Effect of exchange rate changes on cash, cash equivalents, and restricted cash           (16 )             24               21               (26 )             (4 )
Net increase (decrease) in cash, cash equivalents, and restricted cash           466,553               (177,362 )             (142,978 )             516,839               469,436  
Cash, cash equivalents, and restricted cash - beginning of period           780,640               958,002               873,332               730,354               260,918  
Cash, cash equivalents, and restricted cash - end of period $         1,247,193     $         780,640     $         730,354     $         1,247,193     $         730,354  
                   
                   
  Three Months Ended   Year Ended
(in thousands) September 27, 2025   June 28, 2025   September 28, 2024   September 27, 2025   September 28, 2024
Reconciliation of cash, cash equivalents, and restricted cash:                  
Cash and cash equivalents $         1,244,993     $         777,576     $         727,310     $         1,244,993     $         727,310  
Restricted cash           2,200               3,064               3,044               2,200               3,044  
Cash, cash equivalents, and restricted cash $         1,247,193     $         780,640     $         730,354     $         1,247,193     $         730,354  



Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions